134 related articles for article (PubMed ID: 3230337)
1. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
[TBL] [Abstract][Full Text] [Related]
2. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of immunoscintigraphy with 131I anti-CEA and 131I anti-CA 19-9 monoclonal antibody cocktail (IMACIS-1)--report of the phase II study].
Sasaki Y; Inoue T; Oriuchi N; Mitsuhashi N; Nagai T; Igarashi H; Tsujino D; Takahashi T; Sakaki T; Okazaki A
Kaku Igaku; 1990 Apr; 27(4):349-62. PubMed ID: 2198368
[TBL] [Abstract][Full Text] [Related]
4. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M
Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454
[TBL] [Abstract][Full Text] [Related]
5. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies].
Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS
Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
[TBL] [Abstract][Full Text] [Related]
7. [A fundamental study of immunoscintigraphy with 131I-labeled anti-CA 19-9 and anti-CEA monoclonal antibodies--imaging of tumor-bearing mice by IMACIS-1 and cell ELISA with human tumor cells].
Nogami T; Miura H; Ohmi S; Kazahaya Y
Kaku Igaku; 1990 May; 27(5):427-36. PubMed ID: 2395226
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy of recurrences of gynecologic carcinomas.
Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
[TBL] [Abstract][Full Text] [Related]
9. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
[TBL] [Abstract][Full Text] [Related]
10. Role of 131I-labelled anti-CEA/CA 19-9 monoclonal antibodies in the diagnosis and follow-up of gastrointestinal tumors.
Giordano A; Rufini V; Campioni P; Vaccaro A; Troncone L
Int J Rad Appl Instrum B; 1989; 16(2):151. PubMed ID: 2715009
[No Abstract] [Full Text] [Related]
11. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
12. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of radioimmunoscintigraphy using a I-131 anti CEA and CA 19-9 monoclonal antibodies cocktail (IMACIS-1)].
Takahashi T; Tsujino D; Kato Y; Wada Y; Someya K; Itagaki K; Imanishi Y; Ishikawa T; Sakaki T; Sasaki Y
Gan No Rinsho; 1989 Jun; 35(7):828-33. PubMed ID: 2739074
[TBL] [Abstract][Full Text] [Related]
14. Immunoscintigraphy of colorectal carcinoma with an anti-CEA monoclonal antibody: a critical review.
Buraggi GL; Gasparini M; Seregni E
Int J Rad Appl Instrum B; 1991; 18(1):45-50. PubMed ID: 2010305
[TBL] [Abstract][Full Text] [Related]
15. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
[TBL] [Abstract][Full Text] [Related]
16. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
[TBL] [Abstract][Full Text] [Related]
17. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R
Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583
[TBL] [Abstract][Full Text] [Related]
19. Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer.
Ychou M; Pelegrin A; Faurous P; Robert B; Saccavini JC; Guerreau D; Rossi JF; Fabbro M; Buchegger F; Mach JP; Artus JC
Int J Cancer; 1998 Feb; 75(4):615-9. PubMed ID: 9466665
[TBL] [Abstract][Full Text] [Related]
20. [Immunoscintigraphy, an aid to the oncologist--the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125].
Herry JY; Bourguet P; Kerbrat P; Le Prise E; Ben Hassel M; Gedouin D; Richier JL
Allerg Immunol (Paris); 1987 May; 19(5):180-8. PubMed ID: 3330945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]